IDYA - IDEAYA Biosciences, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
IDEAYA Biosciences, Inc.
IPO Date: May 20, 2019
Sector: Healthcare
Industry: Biotech
Market Cap: $3.48B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.58 | 3.02%
Avg Daily Range (30 D): $0.62 | 1.59%
Avg Daily Range (90 D): $0.73 | 2.06%
Institutional Daily Volume
Avg Daily Volume: .46M
Avg Daily Volume (30 D): .55M
Avg Daily Volume (90 D): .76M
Trade Size
Avg Trade Size (Sh.): 66
Avg Trade Size (Sh.) (30 D): 48
Avg Trade Size (Sh.) (90 D): 55
Institutional Trades
Total Institutional Trades: 3,176
Avg Institutional Trade: $2.52M
Avg Institutional Trade (30 D): $3.55M
Avg Institutional Trade (90 D): $3.11M
Avg Institutional Trade Volume: .09M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $3.69M
Avg Closing Trade (30 D): $7.09M
Avg Closing Trade (90 D): $6.6M
Avg Closing Volume: 131.27K
 
News
Apr 13, 2026 @ 11:48 AM
IDEAYA Eye Cancer Trial Data Beats Standard Therap...
Source: Vandana Singh
Dec 17, 2025 @ 3:00 PM
Antibody Optimization Service Market Set to Reach ...
Source: Towards Healthcare
Oct 14, 2025 @ 5:00 PM
Melanoma Clinical Trial Pipeline Accelerates as 15...
Source: Delveinsight
Aug 5, 2025 @ 8:23 PM
IDEAYA (IDYA) Q2 Net Loss Improves 27%
Source: Jesterai
Jul 22, 2025 @ 5:00 PM
Melanoma Market Anticipates a Dynamic Shift During...
Source: Delveinsight
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-1.92 $-1.22 $-1.11
Diluted EPS $-1.94 $-1.22 $-1.11
Revenue $234.13M $8.86M $6.56M
Gross Profit
Net Income / Loss $-175.02M $-112.45M $-98.54M
Operating Income / Loss $-216.95M $-122.29M $-108.54M
Cost of Revenue
Net Cash Flow $158.42M $115.07M $44.96M
PE Ratio